The Wall Street Journal recently published an article titled “IVF Testing Spurs a Debate Over Mosaic Embryos”, discussing the differing opinions regarding mosaicism amongst IVF specialists.
In the words of Prof. Simón, our CSO, “Igenomix tests embryos for about 200 U.S. clinics. Roughly 80% of those clinics classify embryos as either normal or abnormal and don’t want to know if one tests mosaic”.
Access to the full article here.
